Sildenafil in the treatment of pulmonary hypertension

Sildenafil in the treatment of pulmonary hypertension

The paper describes the clinical use of a phosphodiesterase 5 inhibitor (sildenafll) in a patient with primary pulmonary hypertension during a long-term controlled follow-up. The 6-year use of sildenafll as monotherapy for pulmonary hypertension had a significant positive effect as a decrease in the...

Full description

Bibliographic Details
Main Authors:	O. S. Groznova, I. V. Leontyeva, O. V. Todorova
Format:	Article
Language:	Russian
Published:	Ltd. “The National Academy of Pediatric Science and Innovation” 2016-03-01
Series:	Rossijskij Vestnik Perinatologii i Pediatrii
Subjects:	дети легочная артериальная гипертензия распространенность классификация клиническая картина лечение ингибитор фосфодиэстеразы-5 силденафил кардиореспираторный тест.
Online Access:	https://www.ped-perinatology.ru/jour/article/view/286

Similar Items

Pharmacological test with sildenafil at pulmonary hypertension assessing in children with congenital heart diseases
by: O. S. Yanulevich, et al.
Published: (2010-10-01)

THE EFFICACY OF SILDENAFIL THERAPY IN PATIENTS WITH PULMONARY HYPERTENSION OF DIFFERENT ETIOLOGY: INFLUENCE ON THE CLINICAL, FUNCTIONAL, HEMODYNAMIC STATUS, STRUCTURE AND FUNCTION OF THE RIGHT AND LEFT HEART, RIGHT VENTRICULAR-ARTERIAL COUPLING
by: T. V. Martynyuk, et al.
Published: (2017-03-01)

THE COMPLEXITY OF DIAGNOSING IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION
by: D. I. Sadykova, et al.
Published: (2018-11-01)

SUCCESSFUL TREATMENT OF INOPERABLE THROMBOEMBOLIC PULMONARY HYPERTENSION PATIENT WITH SILDENAFIL IN HIGH DOSES
by: Z. H. Dadacheva, et al.
Published: (2014-12-01)

CLINICAL CASE: THERAPY WITH SILDENAFIL IN THE TREATMENT OF IDIOPATHIC PULMONARY HYPERTENSION
by: Z. S. Valieva, et al.
Published: (2015-12-01)

Pulmonary hypertension syndrome in dilation cardiomyopathy patients: sildenafil application to common treatment of chronic heart failure
by: T. A. Abdullaev, et al.
Published: (2016-02-01)

APPLICATION OF PHOSPHODIESTERASE TYPE 5 INHIBITORS SILDENAFIL IN PATIENTS WITH PULMONARY HYPERTENSION
by: T. V. Martynyuk, et al.
Published: (2015-06-01)

Portopulmonary hypertension in a child
by: D. I. Sadykova, et al.
Published: (2016-11-01)

Rapidly progressive idiopathic pulmonary hypertension in a child
by: D. I. Sadykova, et al.
Published: (2016-03-01)

Vasoreactivity testing in pulmonary hypertension associated with congenital heart disease
by: A. A. Shmalts, et al.
Published: (2022-10-01)

CLINICAL CASE: COMBINATION THERAPY WITH BOSENTAN AND SILDENAFIL IN THE TREATMENT OF IDIOPATHIC PULMONARY HYPERTENSION
by: V. V. Bystrov, et al.
Published: (2014-12-01)

Ингибитор фосфодиэстеразы-5 в лечении легочной артериальной гипертензии
Published: (2019-09-01)

EXPERIENCE OF IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION PATIENTS MANAGEMENT IN URAL FEDERAL DISTRICT: FEATURES OFOUTPATIENT-HOSPITAL INTERACTIONS
by: S. V. Shalaev, et al.
Published: (2019-03-01)

Clinical case of a patient with pulmonary capillary hemangiomatosis: rapid progression or lost time?
by: E. A. Devetyarova, et al.
Published: (2021-11-01)

CASE REPORT ON THE SUCCESSFUL USE OF A NEW SELECTIVE PROSTACYCLIN IP RECEPTOR AGONIST, SELEXIPAG, IN A PATIENT WITH IDIOPATHIC PULMONARY HYPERTENSION
by: Z. S. Valieva, et al.
Published: (2019-12-01)

Possibilities of long-term effective treatment of idiopathic pulmonary arterial hypertension by replacing sildenafil with riociguat and using sequential combination therapy: case report
by: S. A. Musashaykhova, et al.
Published: (2022-12-01)

SPECIAL CHARACTERISTICS OF CHRONIC ADENOIDITIS ASSOCIATED WITH CHLAMYDIA INFECTION
by: T. A. Kapustina, et al.
Published: (2013-09-01)

EFFICACY OF MULTIDISCIPLINARY MANAGEMENT OF PULMONARY HYPERTENSION
by: I. R. Gaisin, et al.
Published: (2017-02-01)

ВОЗМОЖНОСТИ МЕДИКАМЕНТОЗНОГО ЛЕЧЕНИЯ ХРОНИЧЕСКОЙ ТРОМБОЭМБОЛИЧЕСКОЙ ЛЕГОЧНОЙ ГИПЕРТЕНЗИИ
by: Т. В. Мартынюк, et al.
Published: (2015-07-01)

CLINICAL CASE OF REPLACEMENT OF ENDOTHELIN RECEPTOR ANTAGONIST (BOSENTAN) BY SOLUBLE GUANYLATE CYCLASE STIMULATOR (RIOCIGUAT) IN THE PATIENT WITH PULMONARY ARTERIAL HYPERTENSION
by: E. A. Devetyarova, et al.
Published: (2018-06-01)

Diagnosis of pulmonary hypertension associated with congenital heart disease. Part 1. Definition, classification and initial examination of patients
by: S. V. Gorbachevsky, et al.
Published: (2021-12-01)

Use of magnesium orotate in children with myocardial hypertrophy in the presence of arterial hypertension
by: V. V. Linyaeva, et al.
Published: (2016-03-01)

Modern approaches to diagnostics and treatment of patients with pulmonary arterial hypertension
by: Т. Г. Волкова, et al.
Published: (2015-10-01)

RENAL ARTERIAL HYPERTENSION IN CHILDREN AND ADOLESCENTS: CAUSES, CLASSIFICATION, DIAGNOSIS
by: N. D. Savenkova
Published: (2017-09-01)

Treatment of emergency conditions (hypertensive crisis) in children with arterial hypertension
by: I. V. Leontyeva, et al.
Published: (2020-07-01)

CARDIOPULMONARY EXCERSISE TESTING IN RISK STRATIFICATION IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
by: I. N. Taran, et al.
Published: (2017-12-01)

Prostacyclin receptor agonist selexipag in a patient with high-risk idiopathic pulmonary arterial hypertension: a case report
by: E. A. Rezukhina, et al.
Published: (2021-09-01)

New perspectives in pulmonary arterial hypertension treatment: 2009 European recommendations
by: T. V. Martynyuk, et al.
Published: (2010-04-01)

CLINICAL FEATURES OF PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONGENITAL SYSTEMIC-TO-PULMONARYSHUNTS
by: S. Ye. Gratsianskaya, et al.
Published: (2017-12-01)

ORAL ANTICOAGULANTS IN PATIENTS WITH DIFFERENT FORMS OF PULMONARY ARTERIAL HYPERTENSION, ASPECTS OF THE PROBLEM
by: S. Ye. Gratsianskaya, et al.
Published: (2017-12-01)

CLINICAL CASE: CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION IN A CHILD
by: D. J. Sadykova, et al.
Published: (2017-03-01)

PULMONAR.Y ARTERIAL HYPERTENSION ASSOCIATED WITH A SYSTEMIC SCLEROSIS: REVIEW OF LITERATURE
by: N. N. Yudkina, et al.
Published: (2015-12-01)

Drug-induced pulmonary artery hypertension
by: O. D. Ostroumova, et al.
Published: (2022-05-01)

PREVALENCE OF ARTERIAL HYPERTENSION AND RISK FACTORS IN YOUNG ADULTS
by: N. T. Vatutin, et al.
Published: (2017-03-01)

Prevalence of metabolic syndrome and its components in patients with arterial hypertension and obesity
by: I. E. Chazova, et al.
Published: (2005-12-01)

OPPORTUNITIES FOR OPTIMIZATION OF DRUG THERAPY BY ENDOTHELIN RECEPTOR ANTAGONISTS FOR THE PATIENT WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION AND ATRIAL SEPTOSTOMY
by: V. V. Gramovich, et al.
Published: (2018-12-01)

THE PREVALENCE OF HYPERTENSION IN THE FEMALE POPULATION DEPENDING ON GESTATIONAL HYPERTENSION IN ANAMNESIS
by: V. . Azizov, et al.
Published: (2016-06-01)

COMPARATIVE CLINICAL CHARACTERISTICS OF PATIENTS WITH VARIOUS FORMS OF PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONGENITAL HEART DISEASE, ACCORDING TO THE CLINICAL CLASSIFICATION
by: S. E. Gratsianskaya, et al.
Published: (2019-12-01)

CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION AND PROBLEMS OF RARE AND INTERDISCIPLINARY DISEASE
by: N. A. Shostak, et al.
Published: (2015-09-01)

Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension associated with congenital heart defects in adults (2021)
by: I. E. Chazova, et al.
Published: (2022-05-01)